Literature DB >> 10766596

Reduction in blood cyclosporine concentrations by orlistat.

E Colman, M Fossler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10766596     DOI： 10.1056/NEJM200004133421518

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Medical management of obesity: present and future therapy.

Authors:  Samuel Klein
Journal:  J Gastrointest Surg       Date:  2003 May-Jun       Impact factor: 3.452

Review 2.  Orlistat-associated adverse effects and drug interactions: a critical review.

Authors:  Theodosios D Filippatos; Christos S Derdemezis; Irene F Gazi; Eleni S Nakou; Dimitri P Mikhailidis; Moses S Elisaf
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 3.  Benefit-risk assessment of orlistat in the treatment of obesity.

Authors:  Priya Sumithran; Joseph Proietto
Journal:  Drug Saf       Date:  2014-08       Impact factor: 5.606

Review 4.  Liver Transplantation in the Obese Cirrhotic Patient.

Authors:  Erin K Spengler; Jacqueline G O'Leary; Helen S Te; Shari Rogal; Anjana A Pillai; Abdullah Al-Osaimi; Archita Desai; James N Fleming; Daniel Ganger; Anil Seetharam; Georgios Tsoulfas; Martin Montenovo; Jennifer C Lai
Journal:  Transplantation       Date:  2017-10       Impact factor: 4.939

5.  A case of atrial fibrillation from cyclosporine toxicity.

Authors:  Pramod Sanghi; Masood Ahmad
Journal:  Indian Pacing Electrophysiol J       Date:  2004-01-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.